REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 199 filers reported holding REVANCE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $95 | -99.4% | 37,340 | -98.8% | 0.00% | -100.0% |
Q1 2024 | $14,855 | +372.6% | 3,019,342 | +744.4% | 0.01% | +400.0% |
Q4 2023 | $3,143 | -48.7% | 357,556 | -33.1% | 0.00% | -75.0% |
Q3 2023 | $6,129 | -13.7% | 534,322 | +90.3% | 0.00% | 0.0% |
Q2 2023 | $7,106 | -20.6% | 280,758 | +1.0% | 0.00% | 0.0% |
Q1 2023 | $8,953 | +57.2% | 277,935 | -9.9% | 0.00% | +33.3% |
Q4 2022 | $5,696 | -99.8% | 308,564 | +228.5% | 0.00% | 0.0% |
Q3 2022 | $2,537,000 | +305.9% | 93,930 | +107.8% | 0.00% | – |
Q2 2022 | $625,000 | +57.0% | 45,206 | +121.4% | 0.00% | – |
Q1 2022 | $398,000 | -88.8% | 20,416 | -90.6% | 0.00% | -100.0% |
Q4 2021 | $3,556,000 | +203.4% | 217,870 | +417.7% | 0.00% | 0.0% |
Q3 2021 | $1,172,000 | +44.9% | 42,084 | +54.2% | 0.00% | – |
Q2 2021 | $809,000 | -52.1% | 27,298 | -54.8% | 0.00% | -100.0% |
Q1 2021 | $1,688,000 | +109.7% | 60,399 | +112.5% | 0.00% | – |
Q4 2020 | $805,000 | -6.3% | 28,417 | -16.8% | 0.00% | -100.0% |
Q3 2020 | $859,000 | -3.0% | 34,162 | -5.8% | 0.00% | 0.0% |
Q2 2020 | $886,000 | +169.3% | 36,270 | +63.3% | 0.00% | – |
Q1 2020 | $329,000 | -63.3% | 22,210 | -59.8% | 0.00% | – |
Q4 2019 | $896,000 | +90.2% | 55,227 | +52.2% | 0.00% | – |
Q3 2019 | $471,000 | -12.5% | 36,283 | -12.6% | 0.00% | – |
Q2 2019 | $538,000 | +1.7% | 41,503 | +24.0% | 0.00% | – |
Q1 2019 | $529,000 | +62.3% | 33,477 | +106.4% | 0.00% | – |
Q4 2018 | $326,000 | -52.2% | 16,217 | -40.8% | 0.00% | – |
Q3 2018 | $682,000 | +100.0% | 27,398 | +120.8% | 0.00% | – |
Q2 2018 | $341,000 | -57.4% | 12,410 | -52.2% | 0.00% | -100.0% |
Q1 2018 | $800,000 | +17.0% | 25,950 | +35.6% | 0.00% | 0.0% |
Q4 2017 | $684,000 | +112.4% | 19,136 | +63.3% | 0.00% | – |
Q3 2017 | $322,000 | +9.5% | 11,719 | +4.9% | 0.00% | – |
Q2 2017 | $294,000 | -29.3% | 11,172 | -44.2% | 0.00% | – |
Q1 2017 | $416,000 | +147.6% | 20,012 | +147.6% | 0.00% | – |
Q4 2016 | $168,000 | +2700.0% | 8,082 | +1925.6% | 0.00% | – |
Q3 2016 | $6,000 | -87.2% | 399 | -88.4% | 0.00% | – |
Q2 2016 | $47,000 | +1466.7% | 3,440 | +1865.7% | 0.00% | – |
Q1 2016 | $3,000 | -80.0% | 175 | -61.4% | 0.00% | – |
Q4 2015 | $15,000 | -98.5% | 453 | -98.7% | 0.00% | -100.0% |
Q3 2015 | $1,016,000 | +8366.7% | 35,022 | +9116.3% | 0.00% | – |
Q2 2015 | $12,000 | -86.4% | 380 | -91.3% | 0.00% | – |
Q1 2015 | $88,000 | +1000.0% | 4,387 | +793.5% | 0.00% | – |
Q4 2014 | $8,000 | +300.0% | 491 | +342.3% | 0.00% | – |
Q3 2014 | $2,000 | -97.0% | 111 | -94.4% | 0.00% | – |
Q2 2014 | $67,000 | +1016.7% | 1,979 | +952.7% | 0.00% | – |
Q1 2014 | $6,000 | – | 188 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
PointState Capital LP | 438,200 | $11,568,000 | 0.13% |